BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16814640)

  • 41. Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor Treatment.
    Poyurovsky M; Weizman A
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):123-125. PubMed ID: 33811191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
    Denys D; Fineberg N; Carey PD; Stein DJ
    Biol Psychiatry; 2007 Feb; 61(3):412-4. PubMed ID: 17241831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quetiapine responsive catatonia in an autistic patient with comorbid bipolar disorder and idiopathic basal ganglia calcification.
    Ishitobi M; Kawatani M; Asano M; Kosaka H; Goto T; Hiratani M; Wada Y
    Brain Dev; 2014 Oct; 36(9):823-5. PubMed ID: 24434185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lorazepam treatment of psychogenic catatonia: an update.
    Salam SA; Kilzieh N
    J Clin Psychiatry; 1988 Dec; 49 Suppl():16-21. PubMed ID: 3058684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine in post-transplant acute mania/bipolar disorder NOS.
    Goracci A; Fagiolini A; Calossi S; Santomauro T; Voltolini L; Fossi A; Rottoli P; Castrogiovanni P
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):723-4. PubMed ID: 18346295
    [No Abstract]   [Full Text] [Related]  

  • 47. [The treatment of OCD].
    Sumitani S; Ohmori T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):442-5. PubMed ID: 12877022
    [No Abstract]   [Full Text] [Related]  

  • 48. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania.
    Kafantaris V; Dicker R; Coletti DJ; Kane JM
    J Child Adolesc Psychopharmacol; 2001; 11(4):409-13. PubMed ID: 11838823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): an exploratory study.
    Fleming K; Thyrum P; Yeh C; Vargo DL; Potkin SG
    J Clin Psychopharmacol; 2001 Oct; 21(5):527-9. PubMed ID: 11593079
    [No Abstract]   [Full Text] [Related]  

  • 51. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quetiapine for treatment-resistant mania.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 2000 Aug; 157(8):1341. PubMed ID: 10910805
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.
    Citrome L; Krakowski M; Greenberg WM; Andrade E; Volavka J
    J Clin Psychiatry; 2001 Nov; 62(11):901. PubMed ID: 11775051
    [No Abstract]   [Full Text] [Related]  

  • 57. Remission of positive and negative symptoms in refractory schizophrenia with a combination of haloperidol and quetiapine: Two case studies.
    Aziz MA; Pepler A; McNeely C; Gorman JM
    J Psychiatr Pract; 2006 Sep; 12(5):332-6. PubMed ID: 16998424
    [No Abstract]   [Full Text] [Related]  

  • 58. SSRI supplementation of antimanic medication in dysphoric mania.
    Rihmer Z; Kiss GH; Kecskés I; Pestality P; György S
    Pharmacopsychiatry; 1998 Jan; 31(1):30-1. PubMed ID: 9524982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    Wong YW; Yeh C; Thyrum PT
    J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ; Lee YJ; Lee YJ; Cho SJ
    J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.